Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng
The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people with haemophilia A in locations where there is little to no access to haemophilia treatment
The company dispatched the first batch of essential medicines worth US $ 30,000 to Ukraine through its embassy in New Delhi
The announcement follows FDA 510(k) clearance of device
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S
The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
Essent continues to broaden its highly characterized, low passage primary cell catalog
Subscribe To Our Newsletter & Stay Updated
